Array reverses losses

Array BioPharma Inc. (Nasdaq: ARRY) reversed year ago losses of 20 cents per diluted share to post a stronger than expected profit for the third quarter of 37 cents per diluted share sending the stock price up 82 cents to close at $7.14.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.